
Amgen buys Immunex in $17.9bn cash and stock deal
Executive Summary
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Intra-Biotech Deal
- Partial Acquisition
- Payment Includes Cash
- Payment Includes Stock
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com